BCRX Analysis

BioCryst Pharmaceuticals, Inc.
Stock Exchange: NASDAQ
Sector: healthcare
16.12
Last session price
16.12
Price now
Currency: USD
Reporting currency: USD
ISIN: US09058V1035
INN:
.

BCRX financial statements

* Numbers in millions
Capitalization * 2 931
EV * 2 704
Number of shares * 182
EPS -1,01
Revenue * 157
Net income * -184
Operating profit * -178
Total liabilities * 695
Net debt * 0
Total assets * 588
Equity * -1 208
Cash and investments * 0
.

BCRX valuation

P/E -15,93
P/B -2,43
P/S 18,65
E/P -6
P/FCF -20,28
.

BCRX profitability

ROE 15%
ROA% -31%
ROIC% -30%